People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MediWound Ltd. | — | Pharmaceuticals | Series B | $30.5M | $243.4M | 2022 |
Boaz Gur-Lavie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Boaz Gur-Lavie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen T. Wills | 1 | 2 |
| Ofer Gonen | 1 | 2 |
| Yaron R. Meyer | 1 | 1 |
| Tzvi R. Palash | 1 | 1 |
| Vickie R. Driver | 1 | 1 |
| Nachum (Homi) Shamir | 1 | 1 |
| Sharon R. Malka | 1 | 1 |
| Ety R. Klinger | 1 | 1 |
| Assaf R. Segal | 1 | 1 |
| Lior R. Rosenberg | 1 | 1 |
| Nissim R. Mashiach | 1 | 1 |
| David R. Fox | 1 | 1 |
| Sharon R. Kochan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.